Maxidex 1 mg / ml Eye Drops
PDF Leaflet Revision Date: 23 February 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Steroid-responsive inflammatory conditions of the eye and external auditory meatus.
Dosage (summary)
1-2 drops into conjunctival sac; 4-6 times daily for mild inflammation, hourly for severe.
Special Populations
- Paediatric patients
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- Pupil-dilating eye drops
Contraindications
- Hypersensitivity to dexamethasone
- Epithelial herpes simplex keratitis
- Vaccinia
- Varicella
- Mycobacterial infection
- Fungal diseases
- Mechanical lacerations
Common side effects
- Ocular discomfort
- Blurred vision
- Dry eye
- Keratitis
Counselling Points
- Avoid contact lenses during treatment
- Monitor for visual disturbances
- Do not discontinue abruptly after long-term use
Serious warnings
- Prolonged use may cause glaucoma
- Monitor intraocular pressure
- May mask infections
Important Disclaimer
The Maxidex 1 mg / ml Eye Drops professional information leaflet below is the property of Novartis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
